Debaters Argue Merits of Surgery in Malignant Meso in Light of MARS2 Data
Erin JungmeyerSurgeon Erin Gillaspie, MD, said surgery still has a role in the treatment of mesothelioma while medical oncologist Hedy Kindler, MD, said newer systemic therapies make surgery obsolete in this space. Read more
Dr. Mark Kris, who leads the IASLC Pathologic Response Project, recently provided an update on efforts to collect data to confirm whether pathologic complete response can predict long-term outcomes. Read more
Multidisciplinary Team to Chair 2025 World Conference
Erin JungmeyerDrs. Umberto Malapelle, Jarushka Naidoo, Isabelle Opitz, and Noemí Reguart will lead WCLC when it returns to Barcelona September 6-9, 2025. Read more
Abstract Submissions, Reviewer Workshop Applications Open for WCLC
Erin JungmeyerThe 2024 World Conference on Lung Cancer may still be months away, but with deadlines approaching, now is the time to submit scientific abstracts and applications for the JTO manuscript reviewer workshop. Read more
Modified Lung Cancer Screening Eligibility Requirements May Reduce Racial Disparities in Lung Cancer Screening, Treatment
Erin JungmeyerAccording to research presented during the North America Conference on Lung Cancer, moving away from pack-years of smoking history to duration of smoking history would increase the number of Black patients who qualify for screening to a rate comparable to that of white patients. Read more
Data Support IMRT as Standard of Care for Locally Advanced NSCLC
Fred GebhartDuring the 2023 World Conference on Lung Cancer, Dr. Stephen Chun said long-term data show intensity-modulated radiation therapy offers an overall survival benefit and reduced toxicity compared to 3D conformal radiation therapy. Read more
Media Training Improves Advocacy Reach, Increases Lung Cancer Awareness
Fred GebhartLungCAN Co-Chair Dusty Donaldson says training program helped just two advocates reach more than 630 million people in 32 states and five countries. Read more
Keynote addresses from renowned investigators Dr. Drew Pardoll and Prof. Laurence Zitvogel will bookend the conference. Learn more in a Q&A with the meeting chairs. Read more
Experts Highlight Advances in Lung Cancer Pathology During World Conference Closing Plenary Session
Krithika Subramanian, PhDDrs. Keith Kerr and Sanja Dacic shared findings from the IASLC Pathology Committee, which is investigating how to best assess pathologic response to neoadjuvant immunotherapy in lung cancer. Read more
Data Show Certain Reproductive Factors Are Associated with Increased Risk of Lung Cancer in Women
Fred GebhartDuring WCLC 2023, Dr. Yan Zhang presented findings that she says support the inclusion of factors such as early menarche and early menopause in lung cancer screening programs. Read more